HIF2A as a prognostic and clinical therapeutic target in ovarian clear cell carcinoma. Jiang M, Yamaguchi K, Hamada K, Hosoe Y, et al. Int J Cancer 2026 Jan 27. doi: 10.1002/ijc.70341.

Read + Share

Amedeo Smart

Independent Medical Education

Jiang M, Yamaguchi K, Hamada K, Hosoe Y, et al. HIF2A as a prognostic and clinical therapeutic target in ovarian clear cell carcinoma. Int J Cancer 2026 Jan 27. doi: 10.1002/ijc.70341.
PMID: 41589342